Lista de obras -

'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course.

artículo científico publicado en 2006

2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis

artículo científico publicado en 2003

20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients

scientific article published on 05 December 2018

5-Azacitidine has limited therapeutic activity in myelofibrosis

artículo científico publicado en 2008

A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway

artículo científico publicado en 2011

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

artículo científico publicado en 2015

A Population-based Study of Chronic Eosinophilic Leukemia-Not Otherwise Specified in the United States

artículo científico publicado en 2020

A bone marrow report of absent stainable iron is not diagnostic of iron deficiency

artículo científico publicado en 2001

A clinical update in polycythemia vera and essential thrombocythemia

artículo científico publicado en 2000

A clinical update on chronic lymphocytic leukemia. I. Diagnosis and prognosis

artículo científico publicado el 1 de abril de 1992

A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities

artículo científico publicado en 1992

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients

artículo científico publicado en 2014

A contemporary approach to the diagnosis and management of polycythemia vera.

artículo científico publicado en 2003

A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisions

scientific article published on 05 January 2010

A critical review of anagrelide therapy in essential thrombocythemia and related disorders

artículo científico publicado en 2005

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

artículo científico publicado en 2009

A long-term retrospective study of young women with essential thrombocythemia

artículo científico publicado en 2001

A long-term study of patients with chronic natural killer cell lymphocytosis

artículo científico publicado en 1999

A longitudinal study of the JAK2(V617F) mutation in myelofibrosis with myeloid metaplasia: analysis at two time points.

artículo científico publicado en 2006

A new murine monoclonal antibody for the diagnosis of erythroleukemia

artículo científico publicado en 1990

A novel pathogenetic mutation in clonal eosinophilia.

artículo científico publicado en 2004

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

artículo científico publicado en 2018

A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis

artículo científico publicado en 2015

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

artículo científico publicado en 2005

A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia

artículo científico publicado en 2001

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2001

A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia

article by R A Mesa et al published 21 June 2007 in Leukemia

A phase-2 trial of low-dose pomalidomide in myelofibrosis ⬇️

artículo científico publicado el 5 de noviembre de 2010

A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.

artículo científico publicado en 2012

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

scholarly article by Naseema Gangat et al published 24 January 2019 in Blood Cancer Journal

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

artículo científico publicado en 2017

A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).

scientific article published on June 2006

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis

artículo científico publicado en 2018

A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies

artículo científico publicado en 2002

A role for tryptase in myeloid disorders?

artículo científico publicado en 2006

A single institutional experience with 43 pregnancies in essential thrombocythemia

artículo científico publicado en 2001

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

artículo científico publicado en 2003

AKT is a therapeutic target in myeloproliferative neoplasms

artículo científico publicado en 2013

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.

artículo científico publicado en 2014

ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia

artículo científico publicado en 2015

Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications.

artículo científico publicado en 2006

Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells.

artículo científico publicado en 2015

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

article

Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes

artículo científico publicado en 2001

Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment

artículo científico publicado en 1997

Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells

artículo científico publicado en 2006

Acute leukemia during pregnancy: a single institutional experience with 17 cases

artículo científico publicado en 2001

Acute leukemia in pregnancy: a single institution experience with 23 patients

artículo científico publicado en 2016

Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3.

artículo científico publicado en 1989

Acute lymphocytic leukemia with eosinophilia: two case reports and a literature review

artículo científico publicado en 2005

Acute megakaryocytic leukemia (M7) in children

artículo científico publicado en 1989

Acute porphyrias: diagnosis and management

artículo científico publicado en 1994

Adult-onset cyclic bicytopenia: a case report and review of treatment of cyclic hematopoiesis

artículo científico publicado en 1989

Advances in molecular diagnostics of myeloproliferative disorders

artículo científico publicado en 2007

Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

artículo científico

Advances in understanding and management of myeloproliferative neoplasms

artículo científico publicado en 2009

Adverse events after imatinib mesylate therapy

artículo científico publicado en 2002

Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients

artículo científico publicado en 2020

Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival.

artículo científico publicado en 2009

Agnogenic myeloid metaplasia

artículo científico publicado en 1997

Agnogenic myeloid metaplasia with pleural extramedullary leukemic transformation

artículo científico publicado en 2004

Agnogenic myeloid metaplasia.

artículo científico publicado en 1995

Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia

artículo científico publicado en 2009

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelofibrosis: A Practical Review

artículo científico publicado en 2016

Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2007

Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.

artículo científico publicado en 2016

Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.

artículo científico publicado en 2018

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

scientific article published on 01 June 2006

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

artículo científico publicado en 2014

Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome

artículo científico publicado en 2001

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.

artículo científico publicado en 2015

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

artículo científico

Anagrelide as a New Platelet-Lowering Agent in Essential Thrombocythemia: Mechanism of Action, Efficacy, Toxicity, Current Indications ⬇️

artículo científico publicado el 1 de enero de 1997

Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia

artículo científico publicado en 2004

Anagrelide: an update on its mechanisms of action and therapeutic potential

artículo científico publicado en 2004

Anemia After Orchiectomy

artículo científico publicado en 1998

Anemia in Adults: A Contemporary Approach to Diagnosis ⬇️

artículo científico publicado el 1 de octubre de 2003

Anemia in myelofibrosis-prevalence, the U2AF1 connection, new treatments

artículo científico publicado en 2017

Anemia in the elderly: how should we define it, when does it matter, and what can be done?

artículo científico publicado en 2007

Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2004

Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series: Polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk‐stratification, and management ⬇️

artículo científico publicado el 1 de marzo de 2011

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome

artículo científico publicado en 2002

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis

artículo científico publicado en 2017

Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis

artículo científico publicado en 2013

Atypical myeloproliferative disorders: diagnosis and management

artículo científico publicado en 2006

Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.

artículo científico publicado en 2006

BCR-ABL1--negative myeloproliferative neoplasms: a review of molecular biology, diagnosis, and treatment

artículo científico publicado en 2011

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

artículo científico publicado en 2015

Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome

artículo científico publicado en 2015

Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment

artículo científico publicado en 2005

Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)

scientific article published on 01 November 2000

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia

artículo científico publicado en 2012

Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes

artículo científico publicado en 2016

Bone marrow granulomas associated with chronic natural killer cell lymphocytosis

artículo científico publicado en 1997

Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2003

Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients

artículo científico publicado en 2004

Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations

artículo científico publicado en 2010

Bortezomib therapy in myelofibrosis: a phase II clinical trial

artículo científico publicado en 2008

Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation

artículo científico publicado en 2001

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience

artículo científico publicado en 2016

C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.

artículo científico publicado en 2006

CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value.

artículo científico publicado en 2015

CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies ⬇️

artículo científico publicado el 1 de abril de 1990

CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival

artículo científico publicado en 2018

CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients

artículo científico publicado en 2009

Calculator-free point-of-care prognostication in myelodysplastic syndromes

artículo científico publicado en 2019

Calreticulin mutations and long-term survival in essential thrombocythemia

artículo científico publicado en 2014

Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia

artículo científico publicado en 2016

Cancer symposium for the practitioner: introduction to solid tumors

artículo científico publicado en 2007

Cardiac tamponade in myelofibrosis: A Mayo clinic series of nine consecutive cases

artículo científico publicado en 2017

Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C.

artículo científico publicado en 2006

Cerebral venous sinus thrombosis associated with essential thrombocytosis in a pediatric patient

artículo científico publicado en 2007

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms.

artículo científico publicado en 2012

Changing trends in the management of chronic granulocytic-leukemia

artículo científico publicado en 1995

Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2.

artículo científico publicado en 2011

Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations

artículo científico publicado en 2009

Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.

artículo científico publicado en 2007

Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution

artículo científico publicado en 2010

Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates

artículo científico

Chronic Myelomonocytic Leukemia: Focus on Clinical Practice

artículo científico publicado en 2016

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management

artículo científico publicado en 2020

Chronic basophilic leukemia: a distinct clinico-pathologic entity?

artículo científico publicado en 2003

Chronic granulocytic leukemia: recent information on pathogenesis, diagnosis, and disease monitoring

artículo científico publicado en 1997

Chronic myelogenous leukemia and myeloproliferative disease

artículo científico publicado en 2004

Chronic myeloid disorders: Classification and treatment overview

artículo científico publicado en 2001

Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

artículo científico publicado en 2011

Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis

artículo científico publicado en 2009

Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment

artículo científico publicado en 2005

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review

artículo científico publicado en 2014

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

artículo científico publicado en 2015

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

artículo científico publicado en 2015

Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management

artículo científico

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management

artículo científico publicado en 2013

Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management

artículo científico publicado en 2016

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management

scientific article published on 01 June 2018

Chronic myelomonocytic leukemia: molecularly contaminated, but not defined.

artículo científico publicado en 2016

Chronic myelomonocytic leukemia: natural history and prognostic determinants

artículo científico

Chronic natural killer cell lymphocytosis

artículo científico publicado en 1996

Chronic natural killer cell lymphocytosis: a descriptive clinical study.

artículo científico publicado en 1994

Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study

artículo científico publicado en 2001

Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management

artículo científico publicado en 2014

Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management

artículo científico

Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.

artículo científico publicado en 2018

Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management

scientific article published on 30 December 2019

Chronic neutrophilic leukemia: new science and new diagnostic criteria

artículo científico publicado en 2018

Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice

artículo científico

Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study ⬇️

artículo científico publicado el 7 de febrero de 2011

Circulating heparin-like anticoagulants: report of five consecutive cases and a review

artículo científico publicado en 1990

Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.

artículo científico publicado en 2011

Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria

artículo científico publicado en 2010

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

artículo científico publicado en 2007

Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system

artículo científico publicado en 2006

Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era.

artículo científico publicado en 2006

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

artículo científico

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

artículo científico publicado en 2008

Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease

artículo científico publicado en 1990

Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia

artículo científico publicado en 1997

Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

artículo científico publicado en 2020

Clinical, genetic, and therapeutic insights into systemic mast cell disease

artículo científico publicado en 2004

Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis.

artículo científico publicado en 2013

Comments on pre-fibrotic myelofibrosis and how should it be managed

scientific article published on 07 March 2019

Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy

artículo científico publicado en 2012

Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2001

Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene

artículo científico publicado en 2014

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

artículo científico publicado en 2011

Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time.

artículo científico publicado en 2006

Concurrent activating KIT mutations in systemic mastocytosis.

artículo científico publicado en 2015

Concurrent inflammatory bowel disease and myelodysplastic syndromes

artículo científico publicado en 1999

Conventional and new treatment options for myelofibrosis with myeloid metaplasia

artículo científico publicado en 2005

Conventional cytogenetics in myelofibrosis: literature review and discussion

scientific article published on 09 January 2009

Current management of polycythemia vera

artículo científico publicado en 2002

Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management

artículo científico publicado en 2001

Current perspective in agnogenic myeloid metaplasia

artículo científico publicado en 1996

Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms

artículo científico publicado en 2014

Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP

scientific article published on 04 December 2019

Cutaneous findings associated with chronic natural killer cell lymphocytosis

artículo científico publicado en 2002

Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.

artículo científico publicado en 2009

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases

artículo científico publicado en 2018

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

artículo científico publicado en 2016

Cytogenetic and molecular detection of residual leukemic cells after allogeneic bone marrow transplantation in chronic granulocytic leukemia

artículo científico publicado el 1 de febrero de 1992

Cytogenetic and molecular genetic aspects of essential thrombocythemia

artículo científico publicado en 2002

Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms

artículo científico publicado en 2010

Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance

artículo científico publicado en 2017

Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates

artículo científico publicado en 2007

Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine

artículo científico publicado en 2009

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

artículo científico publicado en 2010

DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies

artículo científico publicado en 2014

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

artículo científico publicado en 2011

DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia

artículo científico publicado en 2016

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

scientific article published on 17 October 2018

Definition and management of ruxolitinib treatment failure in myelofibrosis

artículo científico publicado en 2014

Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma

artículo científico publicado en 2000

Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia

artículo científico publicado en 2003

Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2005

Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays

artículo científico publicado en 2005

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

artículo científico publicado en 2009

Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis

artículo científico publicado en 2018

Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).

artículo científico publicado en 2012

Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels

article

Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia

artículo científico publicado en 2001

Diagnosing polycythemia vera: a paradigm shift

artículo científico publicado en 1999

Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.

artículo científico publicado en 2000

Diagnostic impact of the 2016 revised who criteria for polycythemia vera

artículo científico publicado en 2017

Differential distribution of CCDC26 glioma-risk alleles in myeloid malignancies with mutant IDH1 compared with their IDH2R140-mutated or IDH-unmutated counterparts.

artículo científico publicado en 2011

Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients

artículo científico publicado en 2012

Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients

artículo científico publicado en 2002

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.

artículo científico publicado en 2014

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

artículo científico publicado en 2012

Disseminated nocardiosis after allogeneic bone marrow transplantation ⬇️

artículo científico publicado el 1 de septiembre de 1997

Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B.

artículo científico publicado en 2002

Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.

artículo científico publicado en 2017

Driver mutations in primary myelofibrosis and their implications

artículo científico publicado en 2017

Drug therapy for myelodysplastic syndrome: building evidence for action

artículo científico publicado en 2006

Drug-drug interaction between bosutinib and warfarin.

artículo científico publicado en 2014

Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia

artículo científico publicado en 2004

Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis.

artículo científico publicado en 2010

EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation

artículo científico publicado en 2006

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

artículo científico publicado en 2018

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma

artículo científico publicado en 1999

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

artículo científico publicado en 2001

Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival

artículo científico publicado en 2007

Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis

artículo científico publicado en 2018

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia

artículo científico publicado en 2001

Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit

artículo científico publicado en 2006

Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro

artículo científico publicado en 2002

Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes

artículo científico publicado en 2015

Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.

artículo científico publicado en 2008

Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis

artículo científico publicado en 2009

Environmental chemical exposures and disturbances of heme synthesis

artículo científico publicado en 1997

Eosinophilia: secondary, clonal and idiopathic

artículo científico publicado en 2006

Erythrocytosis associated with cerebral hemangiomas and multiple venous anomalies

artículo científico publicado en 2020

Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level

artículo científico publicado en 2009

Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice

artículo científico

Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations

artículo científico publicado en 2009

Essential thrombocythemia treatment algorithm 2018.

artículo científico publicado en 2018

Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy

artículo científico publicado en 2008

Essential thrombocythemia: scientific advances and current practice

artículo científico publicado en 2006

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia

artículo científico publicado en 2006

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

artículo científico publicado en 2002

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment

artículo científico publicado en 2012

Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial

artículo científico publicado en 2011

Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.

artículo científico publicado en 2007

Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes.

artículo científico publicado en 2013

Experimental therapy in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2006

Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes.

artículo científico publicado en 2007

Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients

scholarly article by N Fan et al published 19 November 2018 in Blood Cancer Journal

FGFR1 rearranged hematological neoplasms - molecularly defined and clinically heterogeneous

artículo científico publicado en 2018

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

artículo científico publicado en 2004

FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature

artículo científico publicado en 2006

Factors influencing platelet recovery after blood cell transplantation in multiple myeloma ⬇️

artículo científico publicado el 1 de septiembre de 1997

Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility

artículo científico publicado en 2003

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis

artículo científico publicado en 2017

Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia

artículo científico publicado en 2006

Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review

artículo científico publicado en 1998

Follicular dendritic cell sarcoma mimicking diffuse large cell lymphoma: A case report ⬇️

artículo científico publicado el 1 de julio de 1997

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

artículo científico publicado en 2009

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.

artículo científico publicado en 2018

Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients

artículo científico

Genetic Risk Assessment in Myeloproliferative Neoplasms

artículo científico publicado en 2017

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

artículo científico publicado en 2014

Genetic predictors of response to specific drugs in primary myelofibrosis

scholarly article by Domenico Penna et al published 19 November 2018 in Blood Cancer Journal

Genetics: CALR mutations and a new diagnostic algorithm for MPN.

artículo científico publicado en 2014

Genomics basics: DNA structure, gene expression, cloning, genetic mapping, and molecular tests.

artículo científico publicado en 2006

Genotype-Phenotype Correlation of Hereditary Erythrocytosis Mutations, a single center experience

artículo científico publicado en 2018

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

artículo científico publicado en 2019

Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: A retrospective study ⬇️

artículo científico publicado el 1 de septiembre de 1995

Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia

artículo científico publicado en 2004

Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation ⬇️

artículo científico publicado el 1 de mayo de 2003

How I treat myelofibrosis

artículo científico publicado en 2011

How to interpret and pursue an abnormal complete blood cell count in adults

artículo científico publicado en 2005

How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults

artículo científico publicado en 2007

Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia

artículo científico publicado en 2005

Hydroxyurea vindicated: lack of drug leukemogenicity in polycythemia vera

artículo científico publicado en 2005

Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review

artículo científico publicado en 2001

Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia

artículo científico publicado en 2006

Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update

artículo científico publicado en 2010

Hypereosinophilic syndrome with elevated serum tryptase versus systemic mast cell disease associated with eosinophilia: 2 distinct entities? ⬇️

artículo científico publicado el 15 de octubre de 2003

IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia ⬇️

artículo científico publicado el 23 de septiembre de 2010

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F

artículo científico publicado en 2011

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

artículo científico publicado en 2010

IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes

artículo científico publicado en 2011

Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high resolution mate-pair sequencing

artículo científico publicado en 2013

If you feed them, they will come: a prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical center

artículo científico publicado en 2007

Imatinib for systemic mast-cell disease

artículo científico publicado en 2003

Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders

artículo científico publicado en 2004

Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders

artículo científico publicado en 2004

Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders

artículo científico publicado en 2002

Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis

artículo científico publicado en 2004

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

artículo científico publicado en 2016

Immunohistochemical studies of c-kit, transforming growth factor-beta, and basic fibroblast growth factor in mast cell disease

artículo científico publicado en 2002

Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis

artículo científico publicado en 2004

Improving survival trends in primary myelofibrosis: an international study.

artículo científico publicado en 2012

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia ⬇️

artículo científico publicado el 1 de mayo de 2003

Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study

artículo científico publicado en 2013

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

artículo científico

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms.

artículo científico publicado en 2018

Inhibition of JAK-STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells

artículo científico publicado en 2010

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.

artículo científico publicado en 2012

Interferon-α Therapy in Polycythemia Vera and Essential Thrombocythemia ⬇️

artículo científico publicado el 1 de enero de 1997

International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.

artículo científico publicado en 2009

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).

artículo científico publicado en 2006

International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens.

artículo científico publicado en 2011

Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells

artículo científico publicado en 2003

Iron chelation therapy for myelodysplastic syndrome: if and when

artículo científico publicado en 2006

Iron chelation therapy in myelodysplastic syndrome - Cui bono?

artículo científico publicado en 2009

Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?

artículo científico publicado en 2014

Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.

artículo científico publicado en 2011

Issues in the diagnosis and management of essential thrombocythemia

artículo científico publicado en 1994

JAK and MPL mutations in myeloid malignancies

artículo científico publicado en 2008

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations ⬇️

artículo científico publicado el 16 de noviembre de 2010

JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths

artículo científico publicado en 2012

JAK inhibitors in myeloproliferative neoplasms: rationale, current data and perspective

artículo científico publicado en 2011

JAK2 V617F and ringed sideroblasts: not necessarily RARS-T.

artículo científico publicado en 2008

JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease

artículo científico publicado en 2017

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.

artículo científico publicado en 2009

JAK2 in myeloproliferative disorders is not just another kinase.

artículo científico publicado en 2005

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

artículo científico

JAK2 mutations and clinical practice in myeloproliferative neoplasms

artículo científico publicado en 2007

JAK2(V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2006

JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation

artículo científico publicado en 2011

JAK2V617F: more than a clonal marker?

artículo científico publicado en 2009

Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2006

KIT and mastocytosis

artículo científico publicado en 2008

Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.

artículo científico publicado en 2008

Karyotypic analysis in primary myelodysplastic syndromes

artículo científico publicado en 1993

Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders

artículo científico publicado en 2007

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations ⬇️

artículo científico publicado el 19 de agosto de 2010

LNK mutations in JAK2 mutation-negative erythrocytosis.

artículo científico publicado en 2010

Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation

scientific article published on 01 March 1998

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903.

artículo científico publicado en 2010

Lenalidomide therapy in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2006

Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).

artículo científico publicado en 2017

Lenalidomide-induced durable hematological and cytogenetic remission in del(5q)-associated de novo acute myeloid leukemia

artículo científico publicado en 2009

Leukemia risk models in primary myelofibrosis: an International Working Group study.

artículo científico publicado en 2012

Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and Outcome

artículo científico publicado en 2017

Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model

scholarly article by Rangit R Vallapureddy et al published 25 January 2019 in Blood Cancer Journal

Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosis

artículo científico publicado en 2016

Leukocytosis as a risk factor for thrombosis in myeloproliferative neoplasms-biologically plausible but clinically uncertain

artículo científico publicado en 2010

Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patients

artículo científico publicado en 2012

Liver function test abnormalities and their clinical relevance in primary myelofibrosis

artículo científico publicado en 2017

Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F

artículo científico publicado en 2009

Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia

artículo científico publicado en 2005

Long-term experience with imatinib therapy in chronic phase chronic myelogenous leukemia--remarkable activity with room for improvement

artículo científico publicado en 2008

Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome.

artículo científico publicado en 2012

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.

artículo científico publicado en 2008

Long-term use of anagrelide in young patients with essential thrombocythemia

artículo científico publicado en 2001

Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia

artículo científico publicado en 2003

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

artículo científico publicado en 2017

MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms.

artículo científico publicado en 2010

MPL mutations and palpable splenomegaly are independent risk factors for fibrotic progression in essential thrombocythemia

artículo científico publicado en 2016

MPL-mutated essential thrombocythemia: a morphologic reappraisal

scholarly article by Natasha Szuber et al published 20 November 2018 in Blood Cancer Journal

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

artículo científico publicado en 2006

Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates

artículo científico publicado en 2017

Masked polycythemia vera (mPV): results of an international study

artículo científico publicado en 2013

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

artículo científico publicado en 2014

Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years

artículo científico publicado en 2009

Mayo CALR mutation type classification guide using alpha helix propensity

artículo científico publicado en 2018

Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models

artículo científico publicado en 2018

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

artículo científico publicado en 2013

Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methods

artículo científico publicado en 1996

Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates

artículo científico publicado en 2000

Mesenteric venous thrombosis

scholarly article by Ashwani K Singal et al published March 2013 in Mayo Clin Proc

Methotrexate induced seizures associated with acute reversible magnetic resonance imaging (MRI) changes in a patient with acute lymphoblastic leukemia

artículo científico publicado en 2002

Microcytosis in agnogenic myeloid metaplasia: prevalence and clinical correlates.

artículo científico publicado en 2005

Modern diagnosis and treatment of primary eosinophilia

artículo científico publicado en 2005

Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

artículo científico publicado en 2016

Molecular diagnosis of myeloproliferative neoplasms

artículo científico publicado en 2009

Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

scientific article published on 23 October 2008

Momelotinib treatment-emergent neuropathy: prevalence, risk factors and outcome in 100 patients with myelofibrosis.

artículo científico publicado en 2014

Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis

artículo científico publicado en 2017

Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.

artículo científico publicado en 2013

Mutation screening for JAK2V617F: when to order the test and how to interpret the results.

artículo científico publicado en 2006

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

scientific article published on 16 January 2020

Mutational analysis in BCR-ABL-negative classic myeloproliferative neoplasms: impact on prognosis and therapeutic choices

scientific article published on April 2010

Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q).

artículo científico publicado en 2017

Mutations and karyotype predict treatment response in myelodysplastic syndromes

scientific article published on 30 September 2018

Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

artículo científico publicado en 2018

Mutations and prognosis in primary myelofibrosis

artículo científico publicado en 2013

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.

artículo científico publicado en 2014

Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up?

artículo científico publicado en 2011

Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium

artículo científico publicado en 2011

Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis

artículo científico publicado en 2001

Myelodysplasia with fibrosis: a distinct entity?

artículo científico publicado en 2001

Myelodysplastic Syndromes

Myelodysplastic Syndromes—Many New Drugs, Little Therapeutic Progress ⬇️

artículo científico publicado el 22 de septiembre de 2010

Myelodysplastic syndromes: Contemporary review and how we treat

artículo científico publicado en 2016

Myelofibrosis Treatment Algorithm 2018

scholarly article by Ayalew Tefferi et al published 31 July 2018 in Blood Cancer Journal

Myelofibrosis biology and contemporary management

scientific article published on 20 March 2020

Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options

artículo científico publicado en 2006

Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment

artículo científico publicado en 2004

Myeloproliferative Neoplasms

artículo científico publicado en 2017

Myeloproliferative Neoplasms: A Contemporary Review

artículo científico

Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies ⬇️

artículo científico publicado el 10 de enero de 2011

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs

artículo científico publicado en 2012

Myeloproliferative neoplasms 2012: the John M. Bennett 80th birthday anniversary lecture

artículo científico publicado en 2012

Myeloproliferative neoplasms and pregnancy: overview and practice recommendations

scientific article published on 09 December 2020

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

artículo científico publicado en 2018

Myeloproliferative neoplasms: A decade of discoveries and treatment advances

artículo científico publicado en 2015

Myeloproliferative neoplasms: Morphology and clinical practice

artículo científico

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

artículo científico publicado en 2009

Myeloproliferative neoplasms: thrombophilic clonal stem cell diseases

artículo científico publicado en 2009

Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis

artículo científico publicado en 2001

Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts

artículo científico publicado en 2008

Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside

artículo científico publicado en 2002

Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia.

artículo científico publicado en 2003

New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera.

artículo científico publicado en 2015

New drugs in essential thrombocythemia and polycythemia vera ⬇️

artículo científico publicado el 1 de marzo de 1997

New insights into the pathogenesis and drug treatment of myelofibrosis

artículo científico publicado en 2006

Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.

artículo científico publicado en 2015

Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival

artículo científico publicado en 2016

Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?

artículo científico publicado en 2013

Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia.

artículo científico publicado en 2011

Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed?

artículo científico publicado en 2018

Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPN.

artículo científico publicado en 2011

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

artículo científico publicado en 2010

Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia

artículo científico publicado en 2015

Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance

artículo científico publicado en 2017

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance

artículo científico publicado en 2016

Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysis.

artículo científico publicado en 2008

Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease

artículo científico publicado en 2002

Oncogenes in myeloproliferative disorders

artículo científico publicado en 2007

Oncogenic signals as treatment targets in classic myeloproliferative neoplasms

artículo científico publicado en 2009

One thousand patients with primary myelofibrosis: the mayo clinic experience

artículo científico publicado en 2012

Outcome analysis of 34 pregnancies in women with essential thrombocythemia.

artículo científico publicado en 1995

Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients

artículo científico publicado en 2002

Outcome of portal-systemic shunt surgery for portal hypertension associated with intrahepatic obstruction in patients with agnogenic myeloid metaplasia.

artículo científico publicado en 1994

Outcome of recipients of bone marrow transplants who require intensive-care unit support

artículo científico publicado el 1 de febrero de 1992

Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus

artículo científico publicado en 2004

Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic

artículo científico publicado en 2006

Palliative splenectomy in myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2001

Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Resolution with tumor debulking

artículo científico publicado en 1994

Pathogenesis and management of bleeding in essential thrombocythemia and polycythemia vera

artículo científico publicado en 2004

Pathogenesis of myelofibrosis with myeloid metaplasia

artículo científico publicado en 2005

Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis

artículo científico publicado en 2015

Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation

artículo científico publicado en 2001

Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature

artículo científico publicado en 2004

Pernicious anemia revisited

artículo científico publicado en 1994

Personalized management of essential thrombocythemia-application of recent evidence to clinical practice

artículo científico publicado en 2013

Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?

artículo científico publicado en 2007

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia

artículo científico publicado en 1999

Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis

artículo científico publicado en 2008

Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis

artículo científico publicado en 2013

Phase1/-2 study of Pomalidomide in myelofibrosis

artículo científico publicado en 2010

Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients

scientific article published on 10 January 2020

Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome

artículo científico publicado en 2007

Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis

artículo científico publicado en 2012

Platelet count in essential thrombocythemia: the more the better?

artículo científico publicado en 2008

Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay

artículo científico publicado en 2004

Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management

artículo científico

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management

artículo científico publicado en 2015

Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management

artículo científico publicado en 2017

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management

artículo científico publicado en 2018

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management

scientific article published on 24 September 2020

Polycythemia vera and essential thrombocythemia: algorithmic approach

artículo científico publicado en 2017

Polycythemia vera treatment algorithm 2018.

artículo científico publicado en 2018

Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis

artículo científico publicado en 2002

Polycythemia vera-associated pruritus and its management

artículo científico publicado en 2010

Polycythemia vera: a comprehensive review and clinical recommendations

artículo científico publicado en 2003

Polycythemia vera: scientific advances and current practice

artículo científico publicado en 2005

Pomalidomide is active in the treatment of anemia associated with myelofibrosis

artículo científico publicado en 2009

Pomalidomide therapy for multiple myeloma and myelofibrosis: an update

artículo científico publicado en 2011

Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

artículo científico publicado en 1999

Porphyrias: clinical evaluation and interpretation of laboratory tests

artículo científico publicado en 1994

Post-irradiation somnolence syndrome in an adult patient following allogeneic bone marrow transplantation.

artículo científico publicado en 1992

Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia

artículo científico publicado en 2010

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

artículo científico publicado en 2003

Practical aspects in the diagnosis and management of aplastic anemia

artículo científico publicado en 1997

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm

scientific article published on 17 October 2018

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

artículo científico publicado en 2015

Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

artículo científico publicado en 2018

Preclinical and clinical activity of ATP mimetic JAK2 inhibitors

artículo científico publicado el 1 de agosto de 2010

Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.

artículo científico publicado en 2011

Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies

artículo científico publicado en 2009

Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing

artículo científico publicado en 2016

Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia

artículo científico publicado en 1990

Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies

scientific article published on 05 February 2020

Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis

artículo científico publicado en 2006

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

artículo científico publicado en 2007

Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms

artículo científico publicado en 2010

Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders

artículo científico publicado en 2007

Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.

artículo científico publicado en 2018

Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients

artículo científico publicado en 2015

Primary eosinophilic disorders: a concise review

artículo científico publicado en 2008

Primary myelofibrosis

artículo científico publicado en 2008

Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis resear

artículo científico publicado en 2007

Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases

artículo científico publicado en 2008

Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients

artículo científico publicado en 2011

Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management

artículo científico

Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management

artículo científico publicado en 2013

Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management

artículo científico publicado en 2014

Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management

artículo científico publicado en 2016

Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management

artículo científico publicado en 2018

Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management

artículo científico publicado en 2020

Primary thrombocythemia.

artículo científico publicado en 1995

Primer on medical genomics part II: Background principles and methods in molecular genetics

artículo científico publicado en 2002

Primer on medical genomics. Part III: Microarray experiments and data analysis

artículo científico publicado en 2002

Primer on medical genomics. Part IV: Expression proteomics

artículo científico publicado en 2002

Primer on medical genomics. Part VI: Genomics and molecular genetics in clinical practice

artículo científico publicado en 2003

Primer on medical genomics. Part VIII: Essentials of medical genetics for the practicing physician

artículo científico publicado en 2003

Primer on medical genomics. Part XIII: Ethical and regulatory issues

artículo científico publicado en 2004

Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia

artículo científico

Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2005

Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.

artículo científico publicado en 1993

Prognostic impact of RAS mutations in patients with myelodysplastic syndrome

artículo científico publicado en 2013

Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

artículo científico publicado en 2017

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

artículo científico publicado en 2016

Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts.

artículo científico publicado en 2012

Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis ⬇️

artículo científico publicado el 1 de enero de 2011

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

artículo científico publicado en 2017

Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies

artículo científico publicado en 2009

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

artículo científico publicado en 2004

Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease

artículo científico publicado en 2001

Proposal for a revised classification of systemic mastocytosis.

artículo científico publicado en 2010

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

artículo científico publicado en 2007

Pruritus in polycythaemia vera: prevalence, laboratory correlates and management

artículo científico publicado en 2001

Pruritus in primary myelofibrosis: clinical and laboratory correlates.

artículo científico publicado en 2011

Pruritus in primary myelofibrosis: management options in the era of JAK inhibitors

artículo científico publicado en 2016

Pseudoporphyria: a clinical and biochemical study of 20 patients

artículo científico publicado en 2001

Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings

artículo científico publicado en 2005

Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities.

artículo científico publicado en 1996

Pyoderma gangrenosum-like ulcer in a patient with large granular lymphocytic leukemia

artículo científico publicado el 1 de noviembre de 1992

RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2004

Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2001

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis

artículo científico publicado en 2015

Recent progress in the pathogenesis and management of essential thrombocythemia

artículo científico publicado en 2001

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).

artículo científico publicado en 2010

Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.

artículo científico publicado en 2009

Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility

artículo científico publicado en 2005

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients ⬇️

artículo científico publicado el 14 de octubre de 2010

Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management

artículo científico publicado en 2017

Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management"

artículo científico publicado en 2019

Refractory anemia with ring sideroblasts and RARS with thrombocytosis

artículo científico publicado en 2015

Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapy

artículo científico publicado en 2006

Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

artículo científico publicado en 2020

Rethinking the diagnostic criteria of polycythemia vera

artículo científico publicado en 2013

Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion

artículo científico publicado en 1994

Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib.

artículo científico publicado en 2014

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients.

artículo científico publicado en 2018

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

artículo científico publicado en 2013

Revisiting the need for bone marrow examination in chronic myeloid leukemia

artículo científico publicado en 2017

Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis

artículo científico publicado en 2017

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

artículo científico publicado en 2011

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

artículo científico publicado en 2017

Risk factors for leukemic transformation in patients with primary myelofibrosis

artículo científico publicado en 2008

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

artículo científico publicado en 2004

Risk-based management of myelodysplastic syndrome

artículo científico publicado en 2007

Rituximab for Immune Cytopenia in Adults: Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia, and Evans Syndrome ⬇️

artículo científico publicado el 1 de noviembre de 2003

Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

artículo científico publicado en 2007

Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms

artículo científico publicado en 2012

Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients

artículo científico

Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Second Experience.

artículo científico publicado en 2018

Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience.

artículo científico publicado en 2017

Ruxolitinib targets DCs: for better or worse?

artículo científico publicado en 2013

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.

artículo científico publicado en 2013

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

artículo científico publicado en 2011

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial

artículo científico

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

artículo científico publicado en 2013

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis

artículo científico publicado en 2010

Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis

artículo científico publicado en 2011

Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome

artículo científico publicado en 2018

Screening for ASXL1 and SRSF2 mutations is imperative for treatment decision-making in otherwise low or intermediate-1 risk patients with myelofibrosis

artículo científico publicado en 2017

Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia: before or after imatinib?

artículo científico publicado en 2010

Secondary T-cell lymphoma in the setting of nodular lymphocyte predominance Hodgkin's disease

artículo científico publicado en 1992

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

artículo científico publicado en 2003

Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors

artículo científico publicado en 2008

Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus

artículo científico publicado en 2002

Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis

artículo científico publicado en 2011

Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates

scholarly article by Natasha Szuber et al published 19 November 2018 in Blood Cancer Journal

Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients.

artículo científico publicado en 2018

Smouldering mastocytosis: survival comparisons with indolent and aggressive mastocytosis

scientific article published on 09 November 2018

Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms

artículo científico publicado en 2017

Somatic JAK2 mutations and their tumor phenotypes.

artículo científico publicado en 2016

Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic

scientific article published on 30 April 2020

Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells.

artículo científico publicado en 1996

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

artículo científico publicado en 2019

Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases

artículo científico publicado en 2017

Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses

artículo científico publicado en 2002

Splenectomy for massive splenomegaly: long-term results and risks for mortality

artículo científico publicado en 2013

Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients

artículo científico publicado el 1 de octubre de 1992

Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia

artículo científico publicado en 2000

Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.

artículo científico publicado en 2000

Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patients

artículo científico publicado en 2018

Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome

artículo científico publicado en 2003

Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia

artículo científico publicado en 1998

Splenic irradiation in myelofibrosis with myeloid metaplasia: a review

artículo científico publicado en 1999

Splenomegaly and thrombosis risk in essential thrombocythemia: the Mayo Clinic experience.

artículo científico publicado en 2016

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.

artículo científico publicado en 2013

Spontaneous pneumomediastinum and subcutaneous emphysema complicating bronchiolitis obliterans after allogeneic bone marrow transplantation--case report and review of literature

artículo científico publicado en 2001

Stem cell transplantation for the management of primary systemic amyloidosis

artículo científico publicado en 2002

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

artículo científico publicado en 2019

Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case

artículo científico publicado en 2005

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

artículo científico publicado en 2004

Suppressors of cytokine signaling and regulation of clonal erythropoiesis.

artículo científico publicado en 2007

Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia

artículo científico publicado en 2005

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

artículo científico publicado en 2013

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

artículo científico publicado en 2016

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

artículo científico publicado en 2009

Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature

artículo científico publicado en 2010

Systemic mastocytosis: a concise clinical and laboratory review

artículo científico publicado en 2007

Systemic mastocytosis: current concepts and treatment advances.

artículo científico publicado en 2004

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

artículo científico publicado en 2009

TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells

artículo científico publicado en 2010

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

artículo científico publicado en 2007

TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients

artículo científico publicado en 2008

Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosis.

artículo científico publicado en 2015

Targeted next-generation sequencing in blast phase myeloproliferative neoplasms

artículo científico publicado en 2018

Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.

artículo científico publicado en 2017

Targeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle.

artículo científico publicado en 2010

Targeting myeloproliferative neoplasms with JAK inhibitors ⬇️

artículo científico publicado el 1 de marzo de 2011

Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.

artículo científico publicado en 2015

Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studies

artículo científico publicado en 2002

Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trial

artículo científico publicado en 2006

Thalidomide treatment in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos

artículo científico publicado en 2009

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

artículo científico publicado en 2009

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

artículo científico publicado en 2018

The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities

artículo científico publicado en 2017

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances

artículo científico publicado en 2016

The 5q- syndrome: a scientific and clinical update

artículo científico publicado en 1994

The 5q- syndrome: a single-institution study of 43 consecutive patients.

artículo científico publicado en 1993

The Hippocratic Oath, the US Health Care System, and the Affordable Care Act in 2015.

artículo científico publicado en 2015

The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients.

artículo científico publicado en 2009

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

artículo científico publicado en 2005

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

artículo científico publicado en 2005

The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis

artículo científico publicado en 2005

The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

artículo científico publicado en 2009

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients

artículo científico publicado en 2011

The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview

artículo científico publicado en 1998

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

artículo científico publicado en 2013

The biochemical basis of cobalamin deficiency

artículo científico publicado en 1994

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

artículo científico publicado en 2007

The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera

artículo científico

The complete evaluation of erythrocytosis: congenital and acquired

artículo científico publicado en 2009

The diagnosis of polycythemia vera: new tests and old dictums

artículo científico publicado en 2006

The diagnostic interface between histology and molecular tests in myeloproliferative disorders

artículo científico publicado en 2007

The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma

artículo científico publicado en 2005

The effect of arterial hypertension on thrombosis in low-risk polycythemia vera.

artículo científico publicado en 2017

The effects of anagrelide on human megakaryocytopoiesis ⬇️

artículo científico publicado el 1 de octubre de 1997

The forgotten myeloproliferative disorder: myeloid metaplasia

artículo científico publicado en 2003

The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis

artículo científico publicado en 2018

The history of myeloproliferative disorders: before and after Dameshek

artículo científico publicado en 2007

The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes

artículo científico publicado en 2018

The indolent natural history of essential thrombocythemia: a challenge to new drug development

artículo científico publicado en 2005

The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia

artículo científico publicado en 1990

The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy

artículo científico publicado en 2014

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

artículo científico publicado en 2003

The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1.

artículo científico publicado en 2007

The pathogenesis of chronic myeloproliferative diseases

artículo científico publicado en 2001

The presence of JAK2V617F in primary myelofibrosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea

artículo científico publicado en 2008

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

artículo científico publicado en 2014

The prognostic impact of bone marrow fibrosis in primary myelofibrosis.

artículo científico publicado en 2016

The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia

artículo científico publicado en 2017

The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis.

artículo científico publicado en 2014

The recent advances in classic BCR-ABL-negative myeloproliferative disorders.

artículo científico publicado en 2007

The rise and fall of red cell mass measurement in polycythemia vera

artículo científico publicado en 2005

The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.

artículo científico publicado en 2006

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.

artículo científico publicado en 2017

Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy

artículo científico publicado en 2011

Thrombocythaemia and pregnancy

artículo científico publicado en 2003

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin

article

Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia

artículo científico publicado en 2005

Thrombosis in myelofibrosis: prior thrombosis is the only predictive factor and most venous events are provoked ⬇️

artículo científico publicado el 1 de octubre de 2010

Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F.

artículo científico publicado en 2007

Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus

artículo científico publicado en 2009

Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype

artículo científico publicado en 2010

Transient acantholytic dermatosis associated with lymphomatous angioimmunoblastic lymphadenopathy.

artículo científico publicado en 1989

Treatment advances in adult immune thrombocytopenic purpura

artículo científico publicado en 2003

Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.

artículo científico publicado en 2003

Treatment of Myelofibrosis: A Moving Target

artículo científico publicado en 2016

Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-C.

artículo científico publicado en 1998

Treatment of hypereosinophilic syndrome with imatinib mesilate

artículo científico publicado en 2002

Treatment of polycythaemia vera and essential thrombocythaemia

artículo científico publicado en 1998

Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine

artículo científico publicado en 2004

Treatment of systemic mast cell disease: beyond interferon

artículo científico publicado en 2004

Treatment of systemic mast-cell disease with cladribine

artículo científico publicado en 2001

Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt

artículo científico publicado en 2010

Trisomy 13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality

artículo científico publicado en 2009

Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact.

artículo científico publicado en 2014

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates

artículo científico publicado en 2018

U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype.

artículo científico publicado en 2013

Unexplained pulmonary hypertension in chronic myeloproliferative disorders

artículo científico publicado en 2001

Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium

artículo científico publicado en 2012

Upfront low-dose ponatinib (15 mg/day) for multi-TKI resistant chronic myeloid leukemia

artículo científico publicado en 2018

Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia

artículo científico publicado en 2014

Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms a paper from the 2010 William Beaumont hospital symposium on molecular pathology

artículo científico publicado en 2011

Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution

artículo científico publicado en 2007

Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations

artículo científico publicado en 2008

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis.

artículo científico publicado en 2018

Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients

artículo científico publicado en 2016

Variations in bone density among persons of African heritage

artículo científico publicado en 2002

Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients

artículo científico publicado en 2020

Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients

scientific article published on 18 September 2020

Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator

artículo científico publicado en 2002

WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic

scientific article published on 03 April 2020

WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

artículo científico publicado en 2010

Why does my patient have thrombocytosis?

artículo científico

World Health Organization class-independent risk categorization in mastocytosis

article

Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series

artículo científico publicado en 2010

bcr/abl-negative, classic myeloproliferative disorders: diagnosis and treatment

artículo científico publicado en 2005

Lista de obras de

'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course.

2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis

20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients

5-Azacitidine has limited therapeutic activity in myelofibrosis

A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

A Population-based Study of Chronic Eosinophilic Leukemia-Not Otherwise Specified in the United States

A bone marrow report of absent stainable iron is not diagnostic of iron deficiency

A clinical update in polycythemia vera and essential thrombocythemia

A clinical update on chronic lymphocytic leukemia. I. Diagnosis and prognosis

A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients

A contemporary approach to the diagnosis and management of polycythemia vera.

A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisions

A critical review of anagrelide therapy in essential thrombocythemia and related disorders

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

A long-term retrospective study of young women with essential thrombocythemia

A long-term study of patients with chronic natural killer cell lymphocytosis

A longitudinal study of the JAK2(V617F) mutation in myelofibrosis with myeloid metaplasia: analysis at two time points.

A new murine monoclonal antibody for the diagnosis of erythroleukemia

A novel pathogenetic mutation in clonal eosinophilia.

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia

A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia

A phase-2 trial of low-dose pomalidomide in myelofibrosis ⬇️

A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis

A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies

A role for tryptase in myeloid disorders?

A single institutional experience with 43 pregnancies in essential thrombocythemia

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

AKT is a therapeutic target in myeloproliferative neoplasms

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.

ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia

Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications.

Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells.

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes

Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment

Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells

Acute leukemia during pregnancy: a single institutional experience with 17 cases

Acute leukemia in pregnancy: a single institution experience with 23 patients

Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3.

Acute lymphocytic leukemia with eosinophilia: two case reports and a literature review

Acute megakaryocytic leukemia (M7) in children

Acute porphyrias: diagnosis and management

Adult-onset cyclic bicytopenia: a case report and review of treatment of cyclic hematopoiesis

Advances in molecular diagnostics of myeloproliferative disorders

Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

Advances in understanding and management of myeloproliferative neoplasms

Adverse events after imatinib mesylate therapy

Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients

Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival.

Agnogenic myeloid metaplasia

Agnogenic myeloid metaplasia with pleural extramedullary leukemic transformation

Agnogenic myeloid metaplasia.

Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelofibrosis: A Practical Review

Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia

Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.

Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

Anagrelide as a New Platelet-Lowering Agent in Essential Thrombocythemia: Mechanism of Action, Efficacy, Toxicity, Current Indications ⬇️

Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia

Anagrelide: an update on its mechanisms of action and therapeutic potential

Anemia After Orchiectomy

Anemia in Adults: A Contemporary Approach to Diagnosis ⬇️

Anemia in myelofibrosis-prevalence, the U2AF1 connection, new treatments